Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SinoCell Technologies is a prominent Chinese biotechnology company specializing in cell therapy and regenerative medicine. The company operates one of the largest networks of cord blood and stem cell banks in China, providing comprehensive services in cell storage, preparation, and clinical application. Beyond storage, SinoCell is actively developing a pipeline of advanced cell-based therapies, including mesenchymal stem cells (MSCs) for regenerative indications and immune cell therapies like CAR-T and NK cells for oncology. Their business model integrates upstream cell resource preservation with downstream clinical translation and precision medicine. The company is a key player in the National Stem Cell Engineering Research Center, positioning it at the forefront of China's cell therapy sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SinoCell Technologies.